NPI-0052

Salinosporamide A · Celgene

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NPI-0052, covering 2017-09-13 to 2017-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma [Phase 1]

See pricing